Impregnation of Ultrahigh-Molecular-Weight Polyethylene with Amoxicillin in Subcritical Freon R22 Media
- Authors: Zalepugin D.Y.1, Maksimkin A.V.2, Kiselevsky M.V.2,3, Tilkunova N.A.1, Anisimova N.Y.2,3, Chernyshova I.V.1, Spirina T.S.3, Senatov F.S.2, Vlasov M.I.1
-
Affiliations:
- Federal State Unitary Enterprise State Plant of Medicinal Drugs
- National University of Science and Technology MISiS
- Blokhin Russian Cancer Research Center
- Issue: Vol 11, No 8 (2017)
- Pages: 1215-1222
- Section: Article
- URL: https://journal-vniispk.ru/1990-7931/article/view/199815
- DOI: https://doi.org/10.1134/S1990793117080152
- ID: 199815
Cite item
Abstract
The method of impregnation of ultrahigh-molecular-weight polyethylene (UHMWPE) with amoxicillin in subcritical Freon R22 media is developed. For the first time, the possibility of polymer impregnation with a polar substance (a standard antibiotic amoxicillin) in the absence of cosolvents is shown. Cosolvents increase the polarity of the medium and removal of them from the polymer matrix is usually a serious problem. Amoxicillin desorption curves from the impregnated UHMWPE samples are obtained by high-performance liquid chromatography (HPLC). Polymeric samples impregnated with amoxicillin are active against gram-positive and gram-negative microorganisms S. aureus, S. epidermidis, E. faecalis, B. subtilis, and E. coli, allowing them to be considered as real implant models for replacement of bone tissue.
About the authors
D. Yu. Zalepugin
Federal State Unitary Enterprise State Plant of Medicinal Drugs
Author for correspondence.
Email: zaledmit@gmail.com
Russian Federation, Moscow, 111024
A. V. Maksimkin
National University of Science and Technology MISiS
Email: zaledmit@gmail.com
Russian Federation, Moscow, 119049
M. V. Kiselevsky
National University of Science and Technology MISiS; Blokhin Russian Cancer Research Center
Email: zaledmit@gmail.com
Russian Federation, Moscow, 119049; Moscow, 115478
N. A. Tilkunova
Federal State Unitary Enterprise State Plant of Medicinal Drugs
Email: zaledmit@gmail.com
Russian Federation, Moscow, 111024
N. Yu. Anisimova
National University of Science and Technology MISiS; Blokhin Russian Cancer Research Center
Email: zaledmit@gmail.com
Russian Federation, Moscow, 119049; Moscow, 115478
I. V. Chernyshova
Federal State Unitary Enterprise State Plant of Medicinal Drugs
Email: zaledmit@gmail.com
Russian Federation, Moscow, 111024
T. S. Spirina
Blokhin Russian Cancer Research Center
Email: zaledmit@gmail.com
Russian Federation, Moscow, 115478
F. S. Senatov
National University of Science and Technology MISiS
Email: zaledmit@gmail.com
Russian Federation, Moscow, 119049
M. I. Vlasov
Federal State Unitary Enterprise State Plant of Medicinal Drugs
Email: zaledmit@gmail.com
Russian Federation, Moscow, 111024
Supplementary files
